The internal thioester and the covalent binding properties of the complement proteins C3 and C4

Protein Science

Volumn 6, Issue 2, 1997, Pages 263-274

  Law, S K Alex ^a   Dodds, Alister W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

complement; covalent binding; thioester

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; THIOESTER;

BACTERIAL CELL WALL; COMPLEMENT SYSTEM; CONFORMATIONAL TRANSITION; COVALENT BOND; HYDROLYSIS; PRIORITY JOURNAL; PROTEIN BINDING; REACTION ANALYSIS; REVIEW;

EID: 0031043135     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560060201     Document Type: Review

References (95)

1. Alcolea JM, Anton LC, Marques G, Sanchez-Corral P, Vivanco F. 1987. Formation of covalent complexes between the fourth component of human complement and IgG immune aggregates. Complement 4:21-32.
2. Anton LC, Alcolea JM, Sanchez-Corral P, Marques G, Sanchez A, Vivanco F. 1989. C3 binds covalently to the Cγ3 domain of IgG immune aggregates during complement activation by the alternative pathway. Biochem J 257:831-838.
3. Anton LC, Ruiz S, Barrio E, Marques G, Sanchez A, Vivanco F. 1994. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates. Eur J Immunol 24:599-604.
4. Auerbach HS, Burger R, Dodds A, Colten HR. 1990. Molecular basis of complement C3 deficiency in guinea pigs. J Clin Invest 86:96-106.
5. Awdeh ZL, Alper CA. 1980. Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci USA 77:3576-3580.
6. Awdeh ZL, Raum D, Yunis EJ, Alper CA. 1983. Extended HLA/complement allele haplotypes: Evidence for T/t-like complex in man. Proc Natl Acad Sci USA 80:259-263.
7. Belt KT, Carroll MC, Porter RR. 1984. The structural basis of the multiple forms of human complement component C4. Cell 36:907-914.
8. Belt KT, Yu CY, Carroll MC, Porter RR. 1985. Polymorphism of human complement component C4. Immunogenetics 27:173-180.
9. Bhakdi S, Knüffennann H, Fischer H, Wallach DFH. 1974. Interaction between erythrocyte membrane proteins and complement components: II. The identification and peptide composition of complement components C3 and C4 desorbed from erythrocyte membranes. Biochim Biophys Acta 373:295-307.
10. Campbell RD, Dodds AW, Porter RR. 1980. The binding of human complement component C4 to antibody-antigen aggregates. Biochem J 189:67-80.
11. Campbell RD, Gagnon J, Porter RR. 1981. Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. Biochem J 199:359-370.
12. Campbell RD, Milner CM. 1993. MHC genes in autoimmunity. Curr Opin Immunol 5:887-893.
13. Carroll MC, Campbell RD, Bentley DR, Porter RR. 1984. A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature 307:237-241.
14. Carroll MC, Fathallah DM, Bergamaschini L, Alicot EM, Isenman DE. 1990. Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A. Proc Natl Acad Sci USA 87:6868-6872.
15. 2-Macroglobulin. complement, and biologic defense: Antigens, growth factors, microbial proteases, and receptor ligation. Lab Invest 77:792-812.
16. 2-macroglobulin: Implications for the study of peptide and growth factor binding. Biochemistry 30:1551-1560.
17. Czop J, Nussenzweig V. 1976. Studies on the mechanism of solubilization of immune precipitates by serum. J Exp Med 143:615-630.
18. Dalmasso AP, Müller-Eberhard HJ. 1966. Hemolytic activity of lipoprotein-depleted serum and the effect of certain anions on complement. J Immunol 97:680-685.
19. Dalmasso AP, Müller-Eberhard HJ. 1967. Physico-chemical characteristics of the third and fourth component of complement after dissociation from complement-cell complexes. Immunology 13:293-305.
20. de Bruijn MHL, Fey GH. 1985. Human complement component C3: cDNA coding sequence and derived primary structure. Proc Natl Acad Sci USA 82:708-712.
21. Dodds AW, Day AJ. 1993. The phylogeny and evolution of the complement system. In: Whaley K, Loos M, Weiler JM, eds. Complement in health and disease. Dordrecht/Boston/London: Kluwer Academic Publishers, pp 39-88.
22. 2-macroglobulin. Complement 5:89-97.
23. Dodds AW, Law SKA. 1990. The complement component C4 of mammals. Biochem J 265:495-502.
24. Dodds AW, Law SKA, Porter RR. 1985. The origin of the very variable haemolytic activities of the common human complement component C4 allo-types including C4-A6. EMBO J 4:2239-2244.
25. Dodds AW, Law SKA, Porter RR. 1986. The purification and properties of some less common allotypes of the fourth component of human complement. Immunogenetics 24:279-285.
26. Dodds AW, Ren XD, Willis AC, Law SKA. 1996. The reaction mechanism of the internal thioester in the human complement component C4. Nature 379:177-179.
27. Erickson BW, Khan SA. 1983. Synthetic lactam and thiolactone models of protein metastable binding sites. Ann NY Acad Sci 427:167-177.
28. Gadd KJ, Reid KBM. 1981. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum. Biochem J 195:471-480.
29. Goldstein IM, Kaplan HB, Radin A, Frosch M. 1976. Independent effects of IgG and complement upon human polymorphonuclear leukocyte function. J Immunol 117:1282-1287.
30. Gordon J, Whitehead HR, Wormall A. 1926. The action of ammonia on complement: The fourth component. Biochem J 20:1028-1035.
31. 2-macroglobulin. J Biol Chem 254:8669-8678.
32. Harrison RA, Thomas ML, Tack BF. 1981. Sequence determination of the thiolester site of the fourth component of human complement. Proc Natl Acad Sci USA 75:7388-7392.
33. Hauptmann G, Tappeiner G, Schifferli JA. 1988. Inherited deficiency of the fourth component of human complement. Immunodeficiency Rev 1:3-22.
34. Hong K, Kinoshita T, Pramoonjago P, Kim YU, Seya T, Inoue K. 1991. Reconstitution of C5 convertase of the alternative complement pathway with isolated C3b dimer and factors B and D. J Immunol 146:1868-1873.
35. Hostetter MK, Thomas ML, Rosen FS, Tack BF. 1982. Binding of C3b proceeds by a transesterification reaction at the thiolester site. Nature 298:12-15.
36. 2-macroglobulin: Circumstantial evidence for a thiolester. Proc Natl Acad Sci USA 78:2235-2239.
37. Isaac L, Isenman DE. 1992. Structural requirements for thioester bond formation in human complement component C3. Reassessment of the role of thioester bond integrity on the conformation of C3. J Biol Chem 267:10062-10069.
38. Isenman DE, Kells DIC. 1982. Conformational and functional changes in the fourth component of human complement produced by nucleophilic modification and by proteolysis with C1s. Biochemistry 21:1109-1117.
39. Isenman DE, Kells DIC, Cooper NR, Müller-Eberhard HJ, Pangburn MK. 1981. Nucleophilic modification of human complement protein C3: Correlation of Conformational changes with acquisition of C3b-like functional properties. Biochemistry 20:4458-4467.
40. Isenman DE, Young JR. 1984. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. J Immunol 132:3019-3027.
41. Janatova J, Lorenz PE, Schecter AN, Prahl JW, Tack BF. 1980a. Third component of human complement: Appearance of a sulfhydryl group following chemical or enzymatic inactivation. Biochemistry 19:4471-4478.
42. Janatova J, Tack BF, Prahl JW. 1980b. Third component of human complement: Structural requirements for its function. Biochemistry 19:4479-4485.
43. Johnston RB, Klemperer MR, Alper CA, Rosen FS. 1969. The enhancement of bacterial phagocytosis by serum: The role of complement components and two cofactors. J Exp Med 129:1275-1290.
44. 2-macroglobulin and assignment of the chromosomal locus. Proc Natl Acad Sci USA 82:2282-2286.
45. 2-macroglobulin and complement protein C3b. J Am Chem Soc 103:7374-7376.
46. 2-macroglobulin and complement proteins C3 and C4. J Biol Chem 257:11864-11867.
47. Kim YU, Carroll MC, Isenman DE, Nonaka M, Pramoonjago P, Takeda J, Inoue K, Kinoshita T. 1992. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase: Determination of amino acid residues involved in ester linkage formation. J Biol Chem 267:4171-4176.
48. Kinoshita T, Takata Y, Kozono H, Takeda J, Hong K, Inoue K. 1988. C5 convertase of the alternative complement pathway: Covalent linkage between two C3b molecules within the trimolecular complex enzyme. J Immunol 141:3895-3901.
49. Kozono H, Kinoshita T, Kim YU, Takata-Kozono Y, Tsunasawa S, Sakiyama F, Takeda J, Hong K, Inoue K. 1990. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b. J Biol Chem 265:14444-14449.
50. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
51. Lambris JD, Lao Z, Pang J, Alsenz J. 1993. Third component of trout complement: cDNA cloning and conservation of functional sites. J Immunol 151:6123-6134
52. Law SK, Levine RP. 1977. Interaction between the third complement protein and cell surface macromolecules. Proc Natl Acad Sci USA 74:2701-2705.
53. Law SK, Lichtenberg NA, Holcombe FH, Levine RP. 1980. Interaction between the labile binding sites of the fourth (C4) and the fifth (C5) human complement proteins and erythrocyte cell membrane. J Immunol 125:634-639.
54. Law SK, Lichtenberg NA, Levine RP. 1979. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces. J Immunol 123:1388-1394.
55. Law SKA. 1983. Non-enzymic activation of the covalent binding reaction of the complement protein C3. Biochem J 211:381-389.
56. Law SKA, Dodds AW. 1996. Catalysed hydrolysis - The complement quickstep. Immunology Today 17:105.
57. Law SKA, Dodds AW, Porter RR. 1984a. A comparison of the properties of two classes, C4A and C4B, of the human complement component C4. EMBO J 3:1819-1923.
58. Law SKA, Minich TM, Levine RP. 1981. Binding reaction between the third human complement protein and small molecules. Biochemistry 20:7451-7463.
59. Law SKA, Minich TM, Levine RP. 1984b. Covalent binding efficiency of the third and fourth complement proteins in relation to pH, nucleophilicity, and availability of hydroxyl groups. Biochemistry 23:3267-3272.
60. Law SKA, Reid KBM. 1995. Complement, second edition. In: Male D, ed. In focus. Oxford, UK: IRL Press.
61. Mauff G, Abbal M, Alper CA, Christiansen F, Cuccia M, Dawkins R, Doxiadis G, Du Toit E, Giles C, Geserick G, Hauptmann G, Hobart M, Lokki M, McLean R, Nakamura S, O'Neill G, Partanen J, Rittner C, Schneider PM, (WHO-IUIS Nomenclature Sub-Committee). 1993. Revised nomenclature for human complement component C4. J Immunol Methods 163:3-1.
62. 1C-globulin (C′3) in immune hemolysis. J Exp Med 124:33-54.
63. Müller-Eberhard HJ, Policy MJ, Calcott MA. 1967. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement. J Exp Med 125:359-380.
64. Nagase H, Harris ED Jr. 1983. Ovostatin: A novel proteinase inhibitor from chicken egg white. II. Mechanism of inhibition studied with collagenase and thermolysin. J Biol Chem 258:7490-7498.
65. Nagase H, Harris ED Jr, Woessner JF Jr, Brew K. 1983. Ovostatin: A novel proteinase inhibitor from chicken egg white. I. Purification, physicochemical properties, and tissue distribution of ovostatin. J Biol Chem 258:7481-7489.
66. Nicholson A, Brade V, Lee GD, Shin HS, Mayer MM. 1974. Kinetic studies of the formation of the properdin system enzymes on zymosan: Evidence that nascent C3b controls the rate of assembly. J Immunol 112:1115-1123.
67. Nielsen KL, Sottrup-Jensen L. 1993. Evidence from sequence analysis that hen egg-white ovomacroglobulin (ovostatin) is devoid of an internal beta-Cysgamma-Glu thiol ester. Biochim Biophys Acta 1162:230-232.
68. Nonaka M, Nakayama K, Yeul YD, Takahashi M. 1985. Complete nucleotide and derived amino acid sequences of the fourth component of mouse complement (C4). Evolutionary aspects. J Biol Chem 260:10936-10943.
69. O'Neill GJ, Yang SY, Dupont B. 1978. Two HLA-linked loci controlling the fourth component of human complement. Proc Natl Acad Sci USA 75:5165-5169.
70. Pangburn MK. 1992a. Spontaneous reformation of the intramolecular thioester in complement protein C3 and low temperature capture of a conformational intermediate capable of reformation. J Biol Chem 267:8584-8590.
71. 2-macroglobulin, C3 and C4. FEBS Lett 308:280-282.
72. Pangburn MK, Müller-Eberhard HJ. 1980. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement. J Exp Med 152:1102-1114.
73. Pillemer L, Lepow IH, Blum L. 1953. The requirement for a hydrazine-sensitive serum factor and heat-labile serum factors in the inactivation of human C3 by zymosan. J Immunol 77:339-345.
74. Porter RR. 1983. Complement polymorphism, the major histocompatibility complex and associated diseases: A speculation. Mol Biol Med 1:161-168.
75. Porter RR. 1985. The complement components coded in the major histocompatibility complexes and their biological activities. Immunol Rev 87:7-17.
76. 1I3. FEBS Lett 368:87-91.
77. Ren XD. Dodds AW, Law SKA. 1993. The thioester and isotypic sites of complement component C4 in sheep and cattle. Immunogenetics 37:120-128.
78. Sahu A, Kozel TR, Pangburn MK. 1994. Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation. Biochem J 302:429-436.
79. Sahu A, Pangburn MK. 1994. Covalent attachment of human complement C3 to IgG. Identification of the amino acid residue involved in ester linkage formation. J Biol Chem 269:28997-29002.
80. Sahu A, Pangburn MK. 1995. Tyrosine is a potential site for covalent attachment of activated complement component C3. Mol Immunol 32:711-716.
81. Sahu A, Pangbum MK. 1996. Investigation of mechanism-based inhibitors of complement targeting the activated thioester of human C3. Biochem Pharmacol 51:797-804.
82. Sepp A, Dodds AW, Anderson MJ, Campbell RD, Willis AC, Law SKA. 1993. Covalent binding properties of the human complement protein C4 and hydrolysis rate of the internal thioester upon activation. Protein Sci 2:706-716.
83. Shohet JM, Pemberton P, Carroll MC. 1993. Identification of a major binding site for complement C3 on the IgG1 heavy chain. J Biol Chem 268:5866-5871.
84. 2-macroglobulin. Biochem J 193:129-141.
85. Sim RB, Twose TM, Paterson DS, Sim E. 1981. The covalent-binding reaction of complement component C3. Biochem J 193:115-127.
86. 2-Macroglobulin and related thiol ester plasma proteins. In: Putnam FW, ed. The plasma proteins. Orlando, Florida: Academic Press. pp 191-291.
87. 2-macroglobulin. FEBS Lett 123:145-148.
88. 2-macroglobulin cleaved during proteinase complex formation. FEBS Lett 121:275-279.
89. 2-macroglobulin and complement components C3 and C4. Proc Natl Acad Sci USA 82:9-13.
90. Stossel TP, Field RJ, Gitlin JD, Alper CA, Rosen FS. 1975. The opsonic fragment of the third component of human complement (C3). J Exp Med 141:1329-1347.
91. Tack BF, Harrison RA, Janatova J, Thomas ML, Prahl JW. 1980. Evidence for presence of an internal thiolester bond in third component of human complement. Proc NatL Acad Sci USA 77:5764-5768.
92. Theofilopoulos AN, Dixon FJ, Bokisch VA. 1974. Binding of soluble immune complexes to human lymphoblastoid cells: I. Characterization of receptors for IgG Fc and complement and description of binding mechanism. J Exp Med 140:877-894.
93. Venkatesh YP, Levine RP. 1988. The esterase-like activity of covalently bound human third complement protein. Mol Immunol 25:821-828.
94. Venkatesh YP, Minich TM, Law SKA, Levine RP. 1984. Natural release of covalently bound C3b from cell surfaces and the study of this phenomenon in the fluid-phase system. J Immunol 132:1435-1439.
95. Yu CY, Belt KT, Giles CM, Campbell RD, Porter RR. 1986. Structural basis of the polymorphism of human complement components C4A and C4B: Gene size, reactivity and antigenicity. EMBO J 5:2873-2881.